BR0313199A - Derivados h de ácido endiândrico como inibidores de c-maf para o emprego contra asma - Google Patents
Derivados h de ácido endiândrico como inibidores de c-maf para o emprego contra asmaInfo
- Publication number
- BR0313199A BR0313199A BR0313199-8A BR0313199A BR0313199A BR 0313199 A BR0313199 A BR 0313199A BR 0313199 A BR0313199 A BR 0313199A BR 0313199 A BR0313199 A BR 0313199A
- Authority
- BR
- Brazil
- Prior art keywords
- acid derivatives
- endianic
- maf
- use against
- asthma
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title abstract 4
- 102000007987 Proto-Oncogene Proteins c-maf Human genes 0.000 title abstract 2
- 108010089507 Proto-Oncogene Proteins c-maf Proteins 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 241000018415 Beilschmiedia Species 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Medicines Containing Plant Substances (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
"DERIVADOS H DE áCIDO ENDIâNDRICO COMO INIBIDORES DE C-MAF PARA O EMPREGO CONTRA ASMA". A presente invenção refere-se a compostos da fórmula (I), processos para a sua preparação partindo da planta Beilschmiedia fulva, PLA 101037 e seu emprego para a preparação de um medicamento, especialmente para o tratamento de doenças alérgicas, de doenças asmáticas, de sintomas secundários inflamatórios da asma e/ou de doenças, que podem ser tratadas pela inibição de c-maf e NFAT.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10235624A DE10235624A1 (de) | 2002-08-02 | 2002-08-02 | Endiandric acid H und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben |
| PCT/EP2003/007821 WO2004014888A1 (de) | 2002-08-02 | 2003-07-18 | Endiandric acid h derivate als c-maf inhibitoren zur verwendung gegen asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0313199A true BR0313199A (pt) | 2005-06-21 |
Family
ID=30469404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0313199-8A BR0313199A (pt) | 2002-08-02 | 2003-07-18 | Derivados h de ácido endiândrico como inibidores de c-maf para o emprego contra asma |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7019028B2 (pt) |
| EP (1) | EP1529040B1 (pt) |
| JP (1) | JP4598523B2 (pt) |
| AT (1) | ATE314359T1 (pt) |
| AU (1) | AU2003250099B2 (pt) |
| BR (1) | BR0313199A (pt) |
| CA (1) | CA2493483C (pt) |
| DE (2) | DE10235624A1 (pt) |
| DK (1) | DK1529040T3 (pt) |
| ES (1) | ES2254980T3 (pt) |
| IL (1) | IL166439A (pt) |
| MX (1) | MXPA05000387A (pt) |
| WO (1) | WO2004014888A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1944361A1 (en) | 2007-01-11 | 2008-07-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A method for expanding monocytes |
| ES2911505T3 (es) | 2010-10-06 | 2022-05-19 | Inst Catalana Recerca Estudis Avancats | Método para el diagnóstico, pronóstico y tratamiento de la metástasis de cáncer de mama |
| EP2650682A1 (en) | 2012-04-09 | 2013-10-16 | Fundació Privada Institut de Recerca Biomèdica | Method for the prognosis and treatment of cancer metastasis |
| ES2705237T3 (es) | 2012-06-06 | 2019-03-22 | Fundacio Inst De Recerca Biomedica Irb Barcelona | Método para el diagnóstico y el pronóstico de metástasis del cáncer de pulmón |
| US10119171B2 (en) | 2012-10-12 | 2018-11-06 | Inbiomotion S.L. | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis |
| ES2744244T3 (es) | 2012-10-12 | 2020-02-24 | Inbiomotion Sl | Método para el diagnóstico, pronóstico y tratamiento de metástasis de cáncer de próstata usando c-MAF |
| WO2015019125A1 (en) * | 2013-08-05 | 2015-02-12 | Societe De Developpement Et De Recherche Industrielle | Molecular targets for the treatment of wounds, in particular chronic wounds |
| CN117230193A (zh) | 2016-05-25 | 2023-12-15 | 生物运动有限公司 | 基于c-maf状态的乳腺癌治疗性治疗 |
| EP3713581A1 (en) | 2017-11-22 | 2020-09-30 | Inbiomotion S.L. | Therapeutic treatment of breast cancer based on c-maf |
-
2002
- 2002-08-02 DE DE10235624A patent/DE10235624A1/de not_active Withdrawn
-
2003
- 2003-07-18 BR BR0313199-8A patent/BR0313199A/pt not_active Application Discontinuation
- 2003-07-18 DE DE50302084T patent/DE50302084D1/de not_active Expired - Lifetime
- 2003-07-18 JP JP2004526742A patent/JP4598523B2/ja not_active Expired - Fee Related
- 2003-07-18 DK DK03784025T patent/DK1529040T3/da active
- 2003-07-18 MX MXPA05000387A patent/MXPA05000387A/es active IP Right Grant
- 2003-07-18 WO PCT/EP2003/007821 patent/WO2004014888A1/de active IP Right Grant
- 2003-07-18 ES ES03784025T patent/ES2254980T3/es not_active Expired - Lifetime
- 2003-07-18 AT AT03784025T patent/ATE314359T1/de active
- 2003-07-18 CA CA2493483A patent/CA2493483C/en not_active Expired - Fee Related
- 2003-07-18 AU AU2003250099A patent/AU2003250099B2/en not_active Ceased
- 2003-07-18 EP EP03784025A patent/EP1529040B1/de not_active Expired - Lifetime
- 2003-07-25 US US10/627,850 patent/US7019028B2/en not_active Expired - Fee Related
-
2005
- 2005-01-23 IL IL166439A patent/IL166439A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US7019028B2 (en) | 2006-03-28 |
| ATE314359T1 (de) | 2006-01-15 |
| DE50302084D1 (de) | 2006-02-02 |
| ES2254980T3 (es) | 2006-06-16 |
| AU2003250099A1 (en) | 2004-02-25 |
| IL166439A0 (en) | 2006-01-15 |
| CA2493483C (en) | 2011-09-20 |
| DK1529040T3 (da) | 2006-05-08 |
| EP1529040A1 (de) | 2005-05-11 |
| AU2003250099B2 (en) | 2008-12-18 |
| DE10235624A1 (de) | 2004-02-19 |
| JP2006503006A (ja) | 2006-01-26 |
| IL166439A (en) | 2009-12-24 |
| MXPA05000387A (es) | 2005-03-23 |
| JP4598523B2 (ja) | 2010-12-15 |
| US20040138313A1 (en) | 2004-07-15 |
| CA2493483A1 (en) | 2004-02-19 |
| WO2004014888A1 (de) | 2004-02-19 |
| EP1529040B1 (de) | 2005-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Awaad et al. | Anti-inflammatory, antinociceptive and antipyretic effects of some desert plants | |
| Sachdeva et al. | Naringin ameliorates memory deficits in experimental paradigm of Alzheimer's disease by attenuating mitochondrial dysfunction | |
| Pujari et al. | Evaluation of antioxidant and neuroprotective effect of date palm (Phoenix dactylifera L.) against bilateral common carotid artery occlusion in rats | |
| Belviranlı et al. | Curcumin improves spatial memory and decreases oxidative damage in aged female rats | |
| BRPI0507041A (pt) | composto derivados de sulfonamida para o tratamento de doenças seus usos, processo para a preparação dos compostos e combinação de compostos | |
| BRPI0409624A (pt) | 2-hidróxi-3-diaminoalcanos de benzamida | |
| Panja et al. | Uptake and transformation of ciprofloxacin by vetiver grass (Chrysopogon zizanioides) | |
| ECSP034732A (es) | Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias | |
| BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
| BRPI0413490A (pt) | novos compostos | |
| BRPI0408369A (pt) | derivados de indol úteis para o tratamento de doenças | |
| Gu et al. | SIRT1 suppresses p53-dependent apoptosis by modulation of p21 in osteoblast-like MC3T3-E1 cells exposed to fluoride | |
| BR0307564A (pt) | Derivados de nicotinamida úteis como inibidores de pde4 | |
| BRPI0621873B8 (pt) | compostos de piridina condensados ou sais farmaceuticamente aceitáveis dos mesmos, medicamentos, inibidor da jak3 e produto compreendendo os referidos compostos | |
| BR0211119A (pt) | Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto | |
| BRPI0410660A (pt) | derivados de 2-amino-piridina como agonistas de adrenoreceptor ß2 | |
| BR0312232A (pt) | Inibidores de caspases e seus usos | |
| BR0314314A (pt) | Derivados do éter 4-pirrolidina-fenil-benzìlico | |
| Abotsi et al. | Antiarthritic and antioxidant effects of the leaf extract of Ficus exasperata P. Beauv.(Moraceae) | |
| BR0211118A (pt) | Composto, métodos para o tratamento ou prevenção de doenças e para fabricar um composto, intermediário, e, uso de um composto ou sal | |
| BR0313199A (pt) | Derivados h de ácido endiândrico como inibidores de c-maf para o emprego contra asma | |
| BRPI0508927A (pt) | compostos úteis para o tratamento de doenças | |
| BR0307574A (pt) | Derivados de nicotinamida úteis como inibidores de pde4 | |
| Kalmankar et al. | Disulfide-rich cyclic peptides from Clitoria ternatea protect against β-amyloid toxicity and oxidative stress in transgenic Caenorhabditis elegans | |
| Yadav et al. | Protective effects of Spinacia oleracea seeds extract in an experimental model of schizophrenia: possible behavior, biochemical, neurochemical and cellular alterations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B10A | Cessation: cessation confirmed |
Free format text: HOMOLOGADA A DESISTENCIA DO PEDIDO, SOLICITADA ATRAVES DA PETICAO NO 020120004037/RJ DE 16/01/2012. |